Skip to main content
SpringerLink
Log in

Evaluating radical prostatectomy specimens: Therapeutic and prognostic importance

  • Review Article
  • Published:
Virchows Archiv Aims and scope Submit manuscript

Abstract

The pathologic staging of prostate cancer involves determination of the anatomic extent and burden of tumor based on the best available data. Proper examination of radical prostatectomy specimens is critical in determining cancer stage, stratifying patient need for adjuvant treatment, and prediction of patient outcome. Differences exist in methods of handling and sampling specimens, although publication of practice protocols in recent years has led to convergence of opinion. In this report, we evaluate the current aspects of pathologic staging of prostate cancer and assessment of prostatectomy specimens. Recent international agreement on pathologic staging of prostate cancer should allow valid comparisons of surgical treatment from different institutions. The vanishing cancer phenomenon is also briefly discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ackerman DA, Barry JM, Wicklund RA, Olson N, Lowe BA (1993) Analysis of risk factors associated with prostate cancer extension to the surgical margin and pelvic node metastasis at radical prostatectomy. J Urol 150:1845–1850

    Google Scholar 

  2. Adolfsson J (1993) Deferred treatment of low grade stage T3 prostate cancer without distant metastases. J Urol 149:326–329

    Google Scholar 

  3. Armas OA, Aprikian AG, Melamed J, Cordon-Cardo C, Cohen DW, Erlandson R, Fair WR, and Reuter VE (1994) Clinical and pathological effects of neoadjuvant total androgen ablation therapy on clinically localized prostatic adenocarcinoma. Am J Surg Pathol 18:979–991

    Google Scholar 

  4. Association of Directors of Anatomic and Surgical Pathology (1996) Recommendations for the reporting of resected prostate carcinomas. Hum Pathol 27:321–323

    Google Scholar 

  5. Ayala AG, Ro JY, Babaian R, Troncoso P, and Grignon DJ (1989) The prostatic capsule: does it exist? Its importance in the staging and treatment of prostatic carcinoma. Am J Surg Pathol 13:21–27

    Google Scholar 

  6. Bagshaw MA, Cox RS, Ray GR (1988) Status of radiation treatment of prostate cancer at Stanford University. Natl Cancer Inst Monogr 7:47–60

    Google Scholar 

  7. Bahnson RR, Dresner SM, Gooding W, Becich MJ (1989) Incidence and prognostic significance of lymphatic and vascular invasion in radical prostatectomy specimens. Prostate 15:149–155

    Google Scholar 

  8. Bastacky SI, Walsh PC, Epstein JI (1993) Relationship between perineural tumor invasion on needle biopsy and radical prostatectomy capsular penetration in clinical stage B adenocarcinoma of the prostate. Am J Surg Pathol 17:336–341

    Google Scholar 

  9. Blackwell KL, Bostwick DG, Zincke H, et al (1994) Combining prostate specific antigen with cancer and gland volume to predict more reliably pathologic stage: the influence of prostate specific antigen cancer density. J Urol 151:1565–1570

    Google Scholar 

  10. Bostwick DG (1994) The significance of tumor volume in prostate cancer. Urol Ann 8:1–22

    Google Scholar 

  11. Bostwick DG, Cooner WH, Denis L, et al (1992) The association of benign prostatic hyperplasia and cancer of the prostate. Cancer 70:291–301

    Google Scholar 

  12. Bostwick DG, Graham SD Jr, Napalkov P, Abrahamsson P-A, Sant'Agnese PA di, Algaba F, Hoisaeter PA, Lee F, Littrup P, Mostofi FK, Denis L, Schroeder F, Murphy GP (1993) Staging of early prostate cancer: a proposed tumor volume-based prognostic index. Urology 41:403–411

    Google Scholar 

  13. Bostwick DG, Myers RP, Oesterling JE (1994) Staging of prostate cancer. Semin Surg Oncol 10:60–73

    Google Scholar 

  14. Bova GS, Fox WM, Epstein JI (1993) Methods of radical prostatectomy specimen processing: a novel technique for harvesting fresh prostate cancer tissue and review of processing techniques. Mod Pathol 6:201–207

    Google Scholar 

  15. Brawer MK, Chemer MP, Beatie J, et al (1992) Screening for prostatic carcinoma with prostate-specific antigen. J Urol 147:841–844

    Google Scholar 

  16. British Association of Urological Surgeons TNM Subcommittee (1995) The TNM classification of prostate cancer: a discussion of the 1992 classification. Br J Urol 76:279–285

    Google Scholar 

  17. Byar DP, Mostofi FK (1972) Carcinoma of the prostate: prognostic evaluation of certain pathologic features in 208 radical prostatectomies. Cancer 30:5–13

    Google Scholar 

  18. Catalona WJ, Dresner SM (1985) Nerve-sparing radical prostatectomy: extraprostatic tumor extension and preservation of erectile function. J Urol 134:1149–1151

    Google Scholar 

  19. Catalona WJ, Smith DS, Ratliff TL, et al (1991) Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 324:1156–1161

    Google Scholar 

  20. Civantos F, Marcial MA, Banks ER, Ho CK, Speights VD, Drew PA, Murphy WM, Soloway MS (1995) Pathology of androgen deprivation therapy in prostate carcinoma. A comparative study of 173 patients. Cancer 75:1634–1641

    Google Scholar 

  21. Cohen MB, Soloway Ms, Murphy WM (1994) Sampling of radical prostatectomy specimens. How much is adequate? Am J Clin Pathol 101:250–252

    Google Scholar 

  22. Cooner WH, Mosley BR, Rutherford CL Jr, et al (1990) Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate-specific antigen. J Urol 143:1146–1151

    Google Scholar 

  23. Corn BW, Hanks GE, Lee WR, Schultheiss T (1995) Do the current subclassifications of stage T3 adenocarcinoma of the prostate have clinical relevance? Urology 45:484–490

    Google Scholar 

  24. Donahue RE, Miller GJ (1991) Adenocarcinoma of the prostate: biopsy to whole mount. Denver VA experience. Urol Clin North Am 18:449–452

    Google Scholar 

  25. Donaldson ES, Glenn JF (1996) The 1995 staging requirement for approved cancer programs. Urology 47:455–456

    Google Scholar 

  26. Ellison E, Chuang S-S, Zincke H, Ferguson J, Bostwick DG (1996) Prostate adenocarcinoma following androgen deprivation therapy. A comparative study of morphology, morphometry, immunohistochemistry, and DNA ploidy. Pathol Case Rev 1:74–83

    Google Scholar 

  27. Epstein JI (1994) Pathology of prostatic intraepithelial neoplasia and adenocarcinoma of the prostate: prognostic influences of stage, tumor volume, grade, and margins of resection. Semin Oncol 21:527–541

    Google Scholar 

  28. Epstein JI, Carmichael M, Partin AW, Walsh PC (1993) Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinoma of the protate with 5 years of follow-up. J Urol 149:1478–1485

    Google Scholar 

  29. Epstein JI, Walsh PC, Carmichael M, Brendler CB (1994) Pathologic and clinical findings to predict tumor extent of nonpalpable (stage Tlc) prostate cancer. JAMA 271:368–374

    Google Scholar 

  30. Epstein JI, Partin AW, Suavageot J, Walsh PC (1996) Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up. Am J Surg Pathol 20:286–292

    Google Scholar 

  31. Ferguson J, Bostwick DG, Ellison E, Zincke H (1994) Decrease of prostatic intraepithelial neoplasia (PIN) following androgen deprivation therapy in patients with stage T3 prostatic adenocarcinoma. Urology 44:91–95

    Google Scholar 

  32. Ferguson JK, Bostwick DG, Suman V, Zincke H, Oesterling JE (1995) Prostate-specific antigen detected prostate cancer. Pathological characteristics of ultrasound visible versus ultrasound invisible tumors. Eur Urol 27:8–12

    Google Scholar 

  33. Friedman GD, Hiatt RA, Quesenberry CP, Selby JV (1991) Case-control study of screening for prostate cancer by digital rectal examinations. Lancet 337:1526–1529

    Google Scholar 

  34. Goldstein NS, Begin LR, Grody WW, Novak JM, Qian J, Bostwick DG (1995) Minimal or no cancer in radical prostatetomy specimens. Report of 13 cases of the “vanishing cancer phenomenon”. Am J Surg Pathol 19:1002–1009

    Google Scholar 

  35. Gomella LG, White JL, McCue PA, Byrne DS, Mulholland SG (1993) Screening for occult nodal metastases in localized carcinoma of the prostate. J Urol 149:776–778

    Google Scholar 

  36. Graham Jr SD, Bostwick DG, Hoisaeter A, et al (1992) Report of the committee on staging and pathology. Cancer 70 [Suppl]:359–361

    Google Scholar 

  37. Haggman M, Norberg M, Torre M de la, Fritiofsson A, Busch C (1993) Characterization of localized prostatic cancer: distribution, grading and pT-staging in radical prostatectomy specimens. Scand J Urol Nephrol 27:7–13

    Google Scholar 

  38. Hall GS, Kramer CE, Epstein JI (1992) Evaluation of radical prostatectomy specimens: a comparative analysis of sampling methods. Am J Surg Pathol 16:315–324

    Google Scholar 

  39. Hamdy FC, Lawry J, Anderson JB, Parsons MA, Rees RC, Williams JL (1992) Circulating prostate specific antigen-positive cells correlate with metastatic prostate cancer. Br J Urol 69:392–396

    Google Scholar 

  40. Hasson MO, Maksem J (1980) The prostatic perineural space and its relation to tumor spread. An ultrastructural study. Am J Surg Pathol 4:143–148

    Google Scholar 

  41. Henson DE, Hutter RVP, Farrow GM (1994) Practice protocol for the examination of specimens removed from patients with carcinoma of the prostate gland. A publication of the Cancer Committee, College of American Pathologists. Arch Pathol Lab Med 118:779–783

    Google Scholar 

  42. Humphrey PA (1993) Complete histologic serial sectioning of a prostate gland with adenocarcinoma. Am J Surg Pathol 17:468–472

    Google Scholar 

  43. Humphrey PA, Vollmer RT (1990) Intraglandular tumor extent and prognosis in prostatic carcinoma: application of a grid method to prostatectomy specimens. Hum Pathol 21:799–804

    Google Scholar 

  44. Jones EC (1990) Resection margin status in radical retropubic prostatectomy specimens: relationship to type of operation, tumor size, tumor grade, and local extension. J Urol 144:89–93

    Google Scholar 

  45. Labrie F, Dupont A, Suburu R, et al (1992) Serum prostatespecific antigen as pre-sceening test for prostate cancer. J Urol 147:846–850

    Google Scholar 

  46. Lerner SE, Blute ML, Zincke H (1996) Primary surgery for clinical stage T3 adenocarcinoma of the prostate. In: Vogelzang NJ, Scardino PT, Shipley WU, Coffey DS (eds) Comprehensive textbook of genitourinary oncology. Williams and Wilkins, Baltimore, pp 803–811

    Google Scholar 

  47. Littrup PJ, William CR, Egglin TK, Kane RA (1991) Determination of prostate volume with transrectal US for cancer screening. II. Accuracy of in vitro and in vivo techniques. Radiology 179:49–53

    Google Scholar 

  48. McIntire TL, Franzina DA (1986) The presence of benign prostate glands in perineural spaces. J Urol 135:507–509

    Google Scholar 

  49. McNeal JE, Bostwick DG, Kindrachuk RA, Redwine EA, Freiha F, Stamey TA (1986) Patterns of progression in prostate cancer. Lancet 1:60–63

    Google Scholar 

  50. McNeal JE, Villers AA, Redwine EA, Freiha FS, Stamey TA (1990) Capsular penetration in prostate cancer: significance for natural history and treatment. Am J Surg Pathol 14:240–247

    Google Scholar 

  51. Mettlin C, Lee F, Drago J, Murphy GP, Investigators of American Cancer Society National Prostate Cancer Detection Project (1991) Findings on the detection of early prostate cancer in 2425 men. Cancer 67:2949–2957

    Google Scholar 

  52. Montie JE (1990) Significance and treatment of positive margins or seminal vesicle invasion after radical prostatectomy. Urol Clin North Am 17:803–811

    Google Scholar 

  53. Montie JE (1995) Staging of prostate cancer. Current TNM classification and future prospects for prognostic factors. Cancer 75:1814–1818

    Google Scholar 

  54. Montironi R, Muzzonigro G, Galluzzi CM, Giannulis I, Diamanti L, Polito M (1994) Effect of LHRH agonist and flutamide (combination endocrine therapy) on the frequency and location of proliferating cell nuclear antigen and apoptotic bodies in prostatic hyperplasia. J Urol Pathol 2:161–172

    Google Scholar 

  55. Moreno JG, Croce CM, Fischer R, Monne M, Vihko P, Mulholland SG, and Gomella LG (1992) Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res 52:6110–6112

    Google Scholar 

  56. Moul JW, Kahn DG, Lewis DJ, Ho CK, Ross AA, McLeod DG (1994) Immunohistologic detection of prostate cancer pelvic lymph node micrometastases: correlation to preoperative serum prostate-specific antigen. Urology 43:68–73

    Google Scholar 

  57. Murphy WM, Soloway MS, Barrows GH (1991) Pathologic changes associated with androgen, deprivation therapy for prostate cancer. Cancer 68:821–828

    Google Scholar 

  58. Oesterling JE, Suman VJ, Zincke H, Bostwick DG (1993) PSA-detected (Clinical stage T1c or BO) prostate cancer: pathologically significant tumors. Urol Clin North Am 20: 687–693

    Google Scholar 

  59. Ohori M, Scardino PT, Lapin SL, Seale-Hawkins C, Link J, Wheeler TM (1993) The mechanisms and prognostic significance of seminal vesicle involvement by prostate cancer. Am J Surg Pathol 17:1252–1259

    Google Scholar 

  60. Ohori M, Wheeler TM, Kattan MW, Goto Y, Scardino PT (1995) Prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol 154:1818–1824

    Google Scholar 

  61. Parker SL, Tong T, Bolden S, Wingo PA (1996) Cancer statistics, 1996. CA Cancer J Clin 65:5–27

    Google Scholar 

  62. Partin AW, Carter HB, Chan DW, Epstein JI, Oesterling JE, Rock RC, Weber JP, Walsh PC (1990) Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume, and benign hyperplasia. J Urol 143:747–752

    Google Scholar 

  63. Paulson DF, Moul JW, Walther PJ (1990) Radical prostatectomy for clinical stage T1-2N0M0 prostaticc adenocarcinoma long-term results. J Urol 144:1180–1185

    Google Scholar 

  64. Ramchandani P, Schnall MD (1993) Magnetic resonance imaging of the prostate. Semin Roentgenol 28:74–82

    Google Scholar 

  65. Ravery V, Delmas V, Boccon-Gibod LA, Meulemans A, Dauge-Geffroy MC, Toublanc M, Billebaud T, Boccon-Gibod L (1994) Systematic biopsies accurately predict extracapsular extension of prostate cancer and persistent/recurrent detectable PSA after radical prostatectomy. Urology 44:371–377

    Google Scholar 

  66. Ravery V, de la Taille A, Toublanc M, Boccon-Gibod L, Hermien JF, Delmas V, Boccon-Gibod L (1996) Prostate specimen reevaluation in patients with organ confined prostate cancer and postoperative biological recurrence. J Urol 155:1981–1982

    Google Scholar 

  67. Renshaw AA, Chang H, Amico AVD (1996) An abbreviated protocol for processing radical prostatectomy specimens: analysis of tumor grade, stage, margin status, and volume. J Urol Pathol (in press)

  68. Rifkin MD, Zerhouni EA, Garsonis CA, et al. (1990) Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer: results of a multi-institutional cooperative trial. N Engl J Med 323:621–627

    Google Scholar 

  69. Sakr WA, Grignon DJ, Visscher DW, Wolman SR, Crissman JD (1995) Evaluating the radical prostatectomy specimen. A protocol for establishing prognostic parameters and harvesting fresh tissue samples. J Urol Pathol 3:355–364

    Google Scholar 

  70. Sakr W, Wheeler T, Blute M, Bodo M, Calle-Rodrigue R, Henson D, Mostofi FK, Seiffert J, Wojno K, Zincke H (1996) Staging and reporting of prostate cancer. Sampling of the radical prostatectomy specimen. Cancer 78:366–368

    Google Scholar 

  71. Salamao DR, Graham SD, Bostwick DG (1995) Microvascular invasion in prostate cancer correlates with pathologic stage. Arch Pathol Lab Med 119:1050–1054

    Google Scholar 

  72. Sattar AA, Noel J-C, Vanderhaeghen J-J, Schulman CC, Wespes E (1995) Prostate capsule: computerized morphometric analysis of its components. Urology 46:178–181

    Google Scholar 

  73. Scaletscky R, Koch MO, Eckstein CW et al (1994) Tumor volume and stage in carcinoma of the prostate detected by elevations in prostate specific antigen. J Urol 152:129–131

    Google Scholar 

  74. Scardino PT (1989) Is radiotherapy effective for locally advanced (stage C or T3) prostate cancer? Prog Clin Biol Res 303:223–239

    Google Scholar 

  75. Scardino PT, Frankel JM, Wheeler TM, et al (1986) The prognostic significance of post-irradiation biopsy results in patients with prostatic cancer. J Urol 135:510–516

    Google Scholar 

  76. Schellhammer PF (1988) Radical prostatectomy. Patterns of local failure and survival in 67 patients. Urology 31:191–197

    Google Scholar 

  77. Schmid H-P, McNeal JE (1992) An abbreviated standard procedure for accurate tumor volume estimation in prostate cancer. Am J Surg Pathol 16:184–191

    Google Scholar 

  78. Schmid H-P, Ravery V, Billebaud T, Toublanc M, Boccon-Gibod LA, Hermieu JF, Delmas V, Boccon-Gibod L (1996) Early detection of prostate cancer in men with prostatism and intermediate prostate-specific antigen levels. Urology 47:699–703

    Google Scholar 

  79. Shroder FH, Hermanek P, Denis L, et al (1992) The TNM classification of prostate carcinoma. Prostate 4 [Suppl]:129–138

    Google Scholar 

  80. Smith, DM and Murphy WM (1994) Histologic changes in prostate carcinomas treated with Leuprolide (luteinizing hormone-releasing hormone effect). Distinction from poor tumor differentiation. Cancer 73:1472–1477

    Google Scholar 

  81. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine EA (1987) Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 317:909–916

    Google Scholar 

  82. Stamey TA, Villers AA, McNeal JE, Link PC, Freiha FS (1990) Positive surgical margins at radical prostatectomy: importance of the apical dissection. J Urol 143:1166–1173

    Google Scholar 

  83. Stein A, deKernion JB, Smith RB, Dorey F, Patel H (1992) Prostate specific antigen levels after radical prostatectomy in patients with organ confined and locally extensive prostate cancer. J Urol 147:942–947

    Google Scholar 

  84. Tent B, Srigley JR, Boivin JC, Dupont A, Monfette G, Pinault S, Labrie F (1991) Effect of combination endocrine therapy (LHRH agonist and flutamide) on normal prostate and prostatic adenocarcinoma. Am J Surg Pathol 15:111–120

    Google Scholar 

  85. Theiss M, Wirth MP, Manseck A, Frohmuller HGW (1995) Prognostic signficance of capsular invasion and capsular penetration in patients with clinically localized prostate cancer undergoing radical prostatectomy. Prostate 27:13–17

    Google Scholar 

  86. True LD (1994) Surgical pathology examination of the prostate gland. Practice survey by American Society of Clinical Pathologists. Am J Clin Pathol 10:572–579

    Google Scholar 

  87. Voges G, McNeal JE, Redwine EA, Freiha FS, Stamey TA (1992) Morphologic analysis of surgical margins with positive findings in prostatectomy for adenocarcinoma of the prostate. Cancer 69:520–526

    Google Scholar 

  88. Weldon VE, Tavel FR, Neuwirth H, Cohen R (1995) Patterns of positive specimen margins and detectable prostate specific antigen after radical perineal prostatectomy. J Urol 153:1565–1569

    Google Scholar 

  89. Wheeler TM (1989) Anatomic considerations in carcinoma of the prostate. Urol Clin North Am 16:623–634

    Google Scholar 

  90. Wheeler TM, Lebovitz RM (1994) Fresh tissue harvest for research from prostatectomy specimens. Prostate 25:274–279

    Google Scholar 

  91. Zagars GK, Geara FB, Pollack A, Eschenbach AC von (1994) The T classification of clinically localized prostate cancer. An appraisal based on disease outcome after radiation therapy. Cancer 73:1904–1912

    Google Scholar 

  92. Zeitman AL, Edelstein RA, Coen JJ, Babayan RK, Krane RJ (1994) Radical prostatectomy for adenocarcinoma of the prostate: the influence of preoperative and pathologic findings on biochemical disease-free outcome. Urology 43:828–833

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Mayo Clinic, 200 First St. SW, 55905, Rochester, MN, USA

    David G. Bostwick

  2. Department of Pathology, University of Ancona, Ancona, Italy

    Rodolfo Montironi

Authors
  1. David G. Bostwick
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rodolfo Montironi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David G. Bostwick.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bostwick, D.G., Montironi, R. Evaluating radical prostatectomy specimens: Therapeutic and prognostic importance. Virchows Archiv 430, 1–16 (1997). https://doi.org/10.1007/BF01008010

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01008010

Key words

Search

Navigation